Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer (Q79719116)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277760%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277760%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

1 reference

Shang-Rong Ye

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277760%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Hong Yang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277760%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Ke Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277760%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Dan-Dan Dong

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277760%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Xin-Mei Lin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277760%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Shang-Mian Yie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277760%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

2 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277760%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277760%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277760%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277760%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

375-383

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17277760%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/modpathol.3800751

25 December 2019

exact match

0 references

cites work

Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

A class I antigen, HLA-G, expressed in human trophoblasts

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

HLA-G upregulation in pre-malignant and malignant lesions of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

HLA-G suppresses proliferation of CD4(+) T-lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Biology and functions of human leukocyte antigen-G in health and sickness

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Secretion of sHLA-G molecules in malignancies

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Soluble HLA-G molecules are increased in lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

HLA-G has a concentration-dependent effect on the generation of an allo-CTL response

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Histopathological identification of colon cancer with microsatellite instability

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

Adjuvant therapy of colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021

IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800751

7 January 2021